Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 5;120(18):324-325.
doi: 10.3238/arztebl.m2023.0009.

The Management of Atrial Fibrillation with Oral Anticoagulant Drugs

Uwe Zeymer, Steffen Schneider, Matthias Hochadel, Thomas Kleemann, Martin Borggrefe, Ibrahim Akin, Hugo Katus, Dierk Thomas, Karl Werdan, Jochen Senges

The Management of Atrial Fibrillation with Oral Anticoagulant Drugs

Uwe Zeymer et al. Dtsch Arztebl Int. .
No abstract available

PubMed Disclaimer

Figures

Figure
Figure
Flow chart showing stratification of patients into three groups with class I, class IIa, and without indication for oral anticoagulation. Class I indication (CHA2DS2VASc score > 1 men and > 2 women), class IIa indication (CHA2DS2VASc score 1 men and 2 women) and no indication for OAC (CHA2DS2VASc score 0 men and 1 women). Of 2769 persons included in ARENA, 421 were excluded from this analysis (CHA2DS2VASc score not documented n = 242, antithrombotic medication not documented n = 118, after interventional occlusion of atrial appendage n = 23, parenteral anticoagulation n = 38). OAC, oral anticoagulation; LAA, left atrial appendage; KV, cardioversion; PVI, pulmonary vein isolation
See this image and copyright information in PMC

References

    1. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42:373–498. - PubMed
    1. Baldus S, Werdan K, Levenson B, Kuck KH. Klug entscheiden:.. in der Kardiologie. Dtsch Arztebl. 2016;113 A-1312.
    1. Sadlonova M, Senges J, Nagel J, et al. Symptom severity and health-related quality of life in patients with atrial fibrillation: findings from the observational ARENA study. J Clin Med. 2022;11 - PMC - PubMed
    1. Grymonprez M, Simoens C, Steurbaut S, De Backer TL, Lahousse L. Worldwide trends in oral anticoagulation use in patients with atrial fibrillation from 2010 to 2018. Europace. 2022;24:887–898. - PubMed
    1. Hohnloser SH, Basic E, Nabauer M. Uptake in antithrombotic treatment and its association with stroke incidence in atrial fibrillation: insights from a large German claims database. Clin Res Cardiol. 2019;108:1042–1052. - PubMed